Lisette Hilton
Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness for 25 years. Visit www.WordsComeAlive.com.
Navigating the nether regions
After a year of unprecedented growth, are results with nonsurgical vaginal rejuvenation more hype than reality?
The artificial brain as doctor
The artificial brain as doctor
Neural networks do pattern recognition just as a dermatologist would learn patterns and visual data. Computer accuracy rivals that of humans for classifying skin cancer. Deep neural networks and artificial intelligence may have a growing role in practice.
Beyond vaginal rejuvenation
Beyond vaginal rejuvenation
Medical sexual health expert Leah Millheiser, M.D., offers tips for physicians of vaginal rejuvenation patients who may request libido boosting recommendations.
2017’s big breakthroughs
The dermatology community experienced big strides in medical and cosmetic dermatology in 2017. Dermatologists share what they think were major breakthroughs throughout the year.
What’s going to be hot in 2018?
What exciting new devices, drugs and treatments will the New Year bring dermatologists and their patients? Physicians in the specialty and others share what they most anticipate in the coming year.
Daxibotulinumtoxin A for Injection
Studies show pipeline neuromodulator RT002 effective for treating glabellar lines with a 6-month duration.
A new at-home hair loss treatment
Data look hopeful for the iRestore at-home hair growth device, but where does it fit in for optimal, noninvasive hair growth treatment?
Pain control rx
A recent study suggests that rhinoplasty patients may need fewer opioids than surgeons think.
Needle-phobic patients? Laughing gas to the rescue
One surgeon says nitrous oxide is an effective solution for anxiety prone patients during non-surgical procedures.
Prostate Ca test linked to reduction in biopsies
Patients with non-suspicious digital rectal exam findings and total PSA in the 4.0- to 10.0-ng/mL range are far less likely to be biopsied if they’ve undergone Prostate Health Index (phi) testing than if they don’t.

Poll

View Results